Month: October 2008


Memos show FDAers fought preemption

Jane Axelrad, FDA’s associate director of CDER at the time, wrote that, “we
usually find ourselves dealing with situations where sponsors want to minimize
the risk information.” According to Axelrad, preemption wouldn’t be “consistent
with the agency’s role in protecting the public health.” …


NEWS: New public genome database to spark research, unease (BioTechniques Int.)

Though dissenting opinions on the appropriateness of a person’s complete, public
genome are widespread in response to PGP’s approach, the 10 volunteers’ full
genomes are far from being completely sequenced: the privately-funded project is
focusing on only a handful of genes that seem to have the most influence over
disease, behavior, and physical traits. …